The University of Cambridge Metabolic Research Laboratories and its embedded MRC Metabolic Diseases Unit investigate the mechanisms through which metabolic health is maintained and how this is disturbed in disease.
We seek to use that knowledge to aid better treatment and prevention of obesity, Type 2 diabetes and related endocrine and metabolic diseases.
MRL groups encompass skills in genetics, cell biology, cell signalling, neuroendocrinology, bioenergetics, human and animal physiology, experimental medicine and clinical trials.
The MRL is the base for the MRC Metabolic Diseases Unit which supports four programmes of research that aim to improve understanding of the mechanisms responsible for obesity and related metabolic diseases.
Together with a Welcome Strategic Award, it also supports core scientific facilities that underpin basic and experimental science at the MRL.
Latest News
Getting blood glucose sorted while in hospital: the role of the artificial pancreas
A new study, led by Prof Roman Hovorka and published today in the New England Journal of Medicine, shows that an ‘artificial…
A conserved mechanism for membrane phospholipid sensing
A study, published today in Developmental Cell, provides new insights into a biophysical mechanism through which levels of the major membrane…
Success for Professor Paul Fletcher in British Academy Games Awards
Congratulations to MRL PI Prof Paul Fletcher for his part in scooping 5 (five!) BAFTAs for video game Hellblade: Senua’s…
OSTRICH: new study to identify risk factors for obesity-related complications in some young people
Children’s health is at the centre of a new research programme funded by Fondation Botnar, a charitable foundation based in…
